U.S. Markets open in 8 hrs 59 mins

Celldex's stock plummets toward record low after failed drug study

Shares of Celldex Therapeutics Inc. plummeted 40% in premarket trade Monday toward a record low, after the drug maker said a phase 2b trial of its treatment of triple-negative breast cancer failed to meet ...